目的:探讨腹膜腔来源的M2型巨噬细胞对糖尿病小鼠同种异体胰岛移植的抗排斥作用。方法:体外分离诱导C57BL/6小鼠腹膜腔M2型和M0型细胞,流式细胞术鉴定巨噬细胞表型。链脲佐菌素(streptozotocin,STZ)诱导C57BL/6雄性小鼠的糖尿病模型作为受体,分离BALB/c小鼠胰岛细胞移植于C57BL/6糖尿病小鼠左肾包膜下。将移植后糖尿病小鼠随机分为3组,每组8只。于胰岛移植术后1,3,7 d分别经尾静脉输注PBS(islet+PBS组)、2.5×106个M0型巨噬细胞(islet+M0组),2.5×106个M2型巨噬细胞(islet+M2组)。移植术后取尾静脉血监测受体血糖水平的变化,记录胰岛存活时间,并于移植后10 d每组随机抽取2只小鼠处死取左肾做病理学检查,观察移植物形态结构和胰岛素表达水平。结果:Islet+PBS组、islet+M0组和islet+M2组移植物的中位存活时间分别为6.5(4~10),7.5(4~10)和24(﹥15)d;与islet+PBS组和islet+M0组比较,islet+M2组移植物调节血糖正常水平时间和中位存活时间明显延长(P〈0.01)。病理学检查结果显示islet+M2组胰岛移植10 d后移植物结构完整,胰岛素染色阳性;而islet+PBS组和islet+M0组胰岛移植物均被排斥,胰岛素染色阴性,局部见大量淋巴细胞浸润。结论:腹膜腔来源的M2型巨噬细胞能减轻受体对胰岛移植物的免疫排斥反应,延长胰岛移植物的存活时间,从而提高受体对血糖的耐受能力。
Objective: To explore the possibility of using peritoneal alternatively activated M2 macrophages to prevent rejection after islet allotransplantation in a murine model. Methods: Peritoneal monocytes from C57BL/6 mice were induced and modulated to M2 and M0 macrophages in vitro, then the phenotype ofmacrophage was assessed by flow cytometry. C57BL/6 mice were induced diabetic by streptozotocin (STZ) injection and transplanted with islets isolated from BALB/c mice under the left kidney capsule. The recipients were randomly divided to 3 groups (n=8). A total of 2.5x106 M2 macrophages were injected intravenously at 0, 3, 7 d after transplantation in islet+M2 group; 2.5x 106 M0 macrophages were injected intravenously at 0, 3, 7 d after transplantation in islet+M0 group; the mice in islet+PBS group were injected with PBS. Blood glucose was monitored after transplantation. On day 10 after transplantation, 2 recipients in each group were randomly selected and sacrificed, and the left kidneys were resected for pathological examination. Results: Achievement of euglycemia was significantly prolonged after islet transplantation in the islet+M2 group than that in the other two groups (P〈0.01). The median survival time of islet allografts in the islet+PBS group, the islet+M0 group, and the islet+M2 group were 6.5 (4-10), 7.5 (4- 10), and 24(〉 15) d, respectively. Pathological examination also showed that the grafts in islet+M2 group remained an intact structure with positive insulin stain and no apparent lymphocytes infiltration, while the graft was rejected in other 2 groups with negative insulin stain and massive lymphocytes infiltration. Conclusion: Peritoneal alternatively activated M2 macrophages can prevent rejection after islet allotransplantation, prolong the survival time of islet allografts and enhance the tolerance of the recipient to blood glucose in mice.